Shilpa Medicare opened higher at ₹1,018.00, compared with its previous close of ₹1,013.90. During today's session, the stock has traded between ₹935.00 and ₹1,024.00, with an average traded price of ₹969.77. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Shilpa Medicare is now worth
₹ 31,422.00
giving a profit of
₹ 21,422.00 (214.22%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-40.30 (-3.97%)
Day High
₹1,024.00
Day Low
₹935.00
Day Open
₹1,018.00
Prev Close
₹1,013.90
Volume
13,26,735
Value Traded
₹128.66 Cr
1W Return
-5.59%
1M Return
1.30%
3M Return
55.24%
6M Return
131.75%
1Y Return
165.43%
Market Cap (₹ Cr.)
19,042
PE Ratio
66.80
PB Ratio
7.66
Dividend Yield
0.06%
ROE
9.39%
ROCE
12.39%
Book Value (₹)
132.49
Face Value (₹)
1.00
EPS (TTM)
5.16
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-5.59%
6 Week
-
1 Month
1.30%
3 Month
55.24%
9 Month
227.10%
Shilpa Medicare secures Europe GMP approval for Jadcherla Unit 4
Shilpa Medicare secured European GMP certification for its Jadcherla Unit 4 from AGES Austria. Inspection by AGES was conducted between July 27 and July 30, 2026. Certification covers sterile injections, non-sterile tablets, and non-sterile capsules. Approval supports export market compliance for European and global regions.
YesterdayShilpa Medicare promoter group releases pledge on 30 lakh shares
Promoter group released encumbrance on 30,00,000 shares (1.5337% of capital). Release occurred on September 25, 2026, involving pledges with Bajaj Finance Limited. Vishnukant C Bhutada had the largest release at 10,00,000 shares. Remaining encumbered shares persist for key promoters like Deepak Kumar Innani.
17 days agoShilpa Medicare to participate in Nuvama CEO Forum on Sep 28, 2026
Shilpa Medicare officials will attend the Nuvama Emerging India CEO Forum on September 28, 2026. Meetings in Mumbai will include both one-on-one and group sessions with investors. The company confirmed that no Unpublished Price Sensitive Information will be disclosed. Participation is reported under SEBI Listing Regulations for investor conferences.
21 days agoShilpa Medicare's Hyderabad unit gets one remark in USFDA inspection
Shilpa Medicare's Hyderabad unit underwent a USFDA surveillance inspection. The facility received one procedural observation during the review. The finding relates to a process-level issue at the Analytical Services Division. Standard regulatory procedure requires submission of a corrective action plan.
22 days agoShilpa Medicare gets CDSCO approval for OERIS extended-release injection
Shilpa Medicare receives final CDSCO marketing authorization for OERIS. Co MD announces approval as a milestone in supportive cancer care. Product offers extended-release ondansetron injection for up to 120 hours. Patent protection extends until 2039, ensuring long-term exclusivity. Commercial launch across India planned immediately post-approval.
1mo agoShilpa Medicare declares ₹0.60 dividend, adopts FY26 financials
Shilpa Medicare declared a dividend of ₹0.60 per equity share for FY26. Shareholders adopted audited standalone and consolidated financial statements. Mr. Sharath Reddy Kalakota was re-appointed as Director after retiring by rotation. Commission payment to a director of material subsidiary Shilpa Biologicals was approved. The 39th AGM was held via VC/OAVM with 48 members participating remotely.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Shilpa Medicare is now worth
₹ 31,422.00
giving a profit of
₹ 21,422.00 (214.22%)
Note: Past profits do not guarantee future returns.
